Dr. Dimitrios Barmpouletos, MD

Dr. Barmpouletos practices at Clinical Health Care Associates of New Jersey in Vineland, New Jersey.

Dr. Barmpouletos' NPI, 1629260013, was assigned on August 9, 2007. Dr. Barmpouletos holds Delaware license C1- 0009876.

Dr. Barmpouletos' primary practice is Clinical Health Care Associates of New Jersey, at 1076 E Chestnut Ave, Vineland, NJ 08360 in Cumberland County. The practice phone is (856) 216-0300.

Dr. Barmpouletos' primary practice is Clinical Health Care Associates of New Jersey in Vineland, New Jersey. Dr. Barmpouletos is also affiliated with Inspira Medical Center Vineland. The medical group on file is Penn Heart and Vascular Center Cherry Hill. Dmand AI also links Dr. Barmpouletos to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barmpouletos practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Barmpouletos' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Barmpouletos is licensed in Delaware.

CMS data shows 3,955 Medicare services from Dr. Barmpouletos across 28 procedure codes in 2024, for 1,100 Medicare patients. Medicare paid $224,299 for them.

CMS counts 1,100 Medicare patients who saw Dr. Barmpouletos in 2024. The largest group is 75 to 84, with 377 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barmpouletos' median patient age at 62, with 53% women.

In 2024, Dr. Barmpouletos wrote 2,937 Medicare Part D claims for 441 patients. 84% of them were for generic drugs. CMS names the drug for 2,717 of them, across 32 drugs with 11 or more claims each, at $506,257 in total drug cost. In 2023, CMS named 2,123 claims across 30 drugs.

Dr. Barmpouletos accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 89 general payments to Dr. Barmpouletos from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic Vascular, Inc. paid the most, $1,085.